CRVL
Corvel Corp
NASDAQ · Health Care
$48.67
-0.06 (-0.12%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 882.72M | 791.75M | 852.16M | 770.01M | 945.74M |
| Net Income | 93.80M | 75.72M | 137.12M | 106.52M | 124.56M |
| EPS | — | — | — | — | — |
| Profit Margin | 10.6% | 10.1% | 16.1% | 13.8% | 13.2% |
| Rev Growth | +11.5% | +11.5% | +11.6% | +20.4% | +7.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 488.08M | 511.98M | 499.47M |
| Total Equity | — | — | 1.51B | 1.38B | 1.30B |
| D/E Ratio | — | — | 0.32 | 0.37 | 0.38 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 148.20M | 126.28M | 177.50M | 175.74M | 223.10M |
| Free Cash Flow | — | — | 148.61M | 150.62M | 188.36M |